Market Place
Sourcing Support
Lilly to Present at 66th ASH 2024 Annual Meeting
05 Nov 2024 //
#N/A
Lilly’s Jaypirca tipped to capture 60% of BTK leukemia market
22 Jan 2024 //
FIERCE PHARMA
Updated Data from the BRUIN Phase 1/2 Study of Pirtobrutinib Presented at ASH
11 Dec 2023 //
PR NEWSWIRE
Lilly`s Jaypirca blazes CLL trail with FDA approval
04 Dec 2023 //
FIERCE PHARMA
US FDA gives second approval to Eli Lilly`s drug for type of blood cancer
02 Dec 2023 //
PR NEWSWIRE
Eli Lilly`s Jaypirca (pirtobrutinib) Receives Approval in Europe
20 Nov 2023 //
EMA
Lilly Announces Details of Pirtobrutinib Presentations in B-Cell Malignancies
02 Nov 2023 //
PR NEWSWIRE
Lilly Highlights Verzenio and Jaypirca Data at 2023 ASCO Annual Meeting
02 Jun 2023 //
PR NEWSWIRE
Lunsumio™, Jaypirca™ Available at AllianceRx Walgreens Pharmacy
17 May 2023 //
PR NEWSWIRE
JAYPIRCA™ (pirtobrutinib) Now Available from Onco360 for the Treatment of MCL
01 Feb 2023 //
BUSINESSWIRE
Eli Lilly`s Jaypirca gets US nod for mantle cell lymphoma
28 Jan 2023 //
ENDPTS
Lilly says 4 launches will help drive 2023 revenue to $30B
14 Dec 2022 //
FIERCEPHARMA
Lilly’s Loxo rounds out the PhI/II data for lymphoma drug under FDA review
12 Dec 2022 //
ENDPTS
ASH: Should existing BTKs worry about Lilly`s newcomer?
12 Dec 2022 //
FIERCEBIOTECH
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.